JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Resveratrol treatment ameliorates hepatic damage via the TGF-β/SMAD signaling pathway in a phenobarbital/CCl4-induced hepatic fibrosis model

  • 0Department of Medical Biology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Iranian Journal of Basic Medical Sciences +

|

July 26, 2024

|

July 26, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Resveratrol treatment may prevent liver damage by regulating biochemical parameters and controlling TGF-β1/SMAD signaling in a rat model of hepatic fibrosis. This supports its potential for liver health.

Area Of Science

  • Hepatology and Pharmacology
  • Molecular Biology
  • Biochemistry

Background

  • Liver fibrosis is a pathological condition involving excessive extracellular matrix accumulation.
  • The transforming growth factor-beta (TGF-β)/SMAD signaling pathway plays a crucial role in liver fibrosis progression.
  • Understanding the molecular mechanisms underlying liver fibrosis is essential for developing effective treatments.

Purpose Of The Study

  • To investigate the therapeutic effects of resveratrol on liver fibrosis.
  • To examine resveratrol's impact on the TGF-β/SMAD signaling pathway.
  • To evaluate resveratrol's influence on biochemical parameters, apoptosis, and liver regeneration in a rat model.

Main Methods

  • A rat model of hepatic fibrosis was induced using phenobarbital and carbon tetrachloride (CCl4).
  • Resveratrol was administered to assess its effects on fibrosis, apoptosis, and liver regeneration.
  • Immunohistochemistry, TUNEL, Masson's Trichome staining, and biochemical assays were employed to analyze liver tissue and function.

Main Results

  • Resveratrol treatment modulated SMAD2, SMAD3, SMAD4, and SMAD7 mRNA expression levels.
  • Resveratrol administration reduced biochemical markers of liver damage, collagen accumulation, and apoptosis.
  • The study observed enhanced tissue regeneration in resveratrol-treated groups.

Conclusions

  • Resveratrol ameliorates hepatic fibrosis by regulating biochemical parameters and the TGF-β1/SMAD signaling pathway.
  • Resveratrol demonstrates potential in reducing apoptosis and promoting liver regeneration.
  • Resveratrol may serve as a beneficial agent for preventing liver damage in hepatic fibrosis.

Keywords: